HELENE HENDRIXSON: CANCER SURVIVOR
(-conclusion-)
Helene would try this risky procedure a second time,
with similar results.
Then, in August of 1998, when her tumors had been
gone for several months, Helene decided to discontinue
taking the cesium, but continued taking the aloe vera
concentrate. This time, the tumors did not return.
Today, five and a half years after she was first
diagnosed with non-Hodgkins Lymphoma and roughly four
and a half years after completing the cesium protocol,
Helene Hendrixson is still cancer free.
What is more remarkable, however, is the continuing
resistance of her doctors to even consider the
possibility that her complete remission could have been
achieved through the use of cesium and aloe vera.
Whenever she attempts to bring the subject up with them,
their only response is derisive laughter – this despite
the tangible evidence from Helene’s astounding recovery
that the treatment worked! They know that Helene took no
other treatment, and yet they refuse to even consider
the possibility that a non-traditional, natural therapy
might have helped!
What is perhaps the most disturbing about their
refusal to recognize the truth, however, are the
consequences of such a close-minded attitude for the
doctors’ other patients – especially those who had
exhausted all conventional approaches. Wouldn’t such
patients at least want to know that they had one last
chance for survival? Wouldn’t they want the opportunity
to decide for themselves whether or not to try cesium
and aloe? Even if the doctors had doubts about the
effectiveness of the High pH Therapy, the chance for
realizing some benefit could hardly be worse than the 5%
(at best) offered by a Phase I trial. How many patients
may have died because their physicians withheld this
potentially life-saving information?
And, for that matter, what of the phase I clinical
trial Helene’s doctor was so insistent she participate
in? Although the results have not been published, it
does not appear that the trial was successful. Indeed,
the doctors running the trial initiated a new one, using
Interleuken-2 as an immune system booster, abandoning
the plant extract they were using in the trial Helene
was supposed to join. So, in the end, Helene’s refusal
to allow herself to become a human guinea pig probably
saved her life.
To Helene, however, what is most important is that
she is cancer-free five and one half years after her
initial diagnosis – an achievement the cancer
establishment uses to define a “cure.” Her doctors may
not want to recognize the truth, but for Helene, her
continued survival is evidence enough.
Helen Hendrixson: Cancer
Survivor 1 -
2 -
3 -
4 -
5
Click here to order
